J&J, Bayer Fight Ex-FDA Head's Xarelto Warning Testimony
A pair of Johnson & Johnson and Bayer AG units pushed back Wednesday against a onetime U.S. Food and Drug Administration chief's trial testimony that they provided inadequate warnings about the...To view the full article, register now.
Already a subscriber? Click here to view full article